OAC
TNYA icon

OMERS Administration Corp’s Tenaya Therapeutics TNYA Stock Holding History

OMERS Administration Corp’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-207,100
Closed -$143K – 1134
2026
Q1 		$143K Sell
207,100
-29,300
-12% -$21.6K ﹤0.01% 968
2025
Q4 		$168K Buy
+236,400
New +$322K ﹤0.01% 931

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OMERS Administration Corp's TNYA Position: Q2 2026 in Review

OMERS Administration Corp sold out of Tenaya Therapeutics (TNYA) in Q2 2026, closing a stake of 207,100 shares — an estimated $143K sold.

OMERS Administration Corp first reported a position in TNYA in Q4 2025 and held it in 2 quarters. The position peaked at $168K in Q4 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • OMERS Administration Corp reported no remaining Tenaya Therapeutics position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 207,100 Tenaya Therapeutics shares in Q2 2026, an estimated $143K.
  • OMERS Administration Corp first reported a position in Tenaya Therapeutics in Q4 2025 and held it in 2 quarters.
  • OMERS Administration Corp's Tenaya Therapeutics position peaked at $168K in Q4 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.